Series B - SAB Biotherapeutics - Jul 17, 2020 Funding Round Profile - Cointime

Bitcoin $98,778.44 +3.09%
Ethereum $3,361.60 +8.93%
BNB $635.19 +5.34%
Optimism $2.04 +23.91%
Arbitrum $0.77 +14.74%
Solana $262.26 +11.19%
Polygon $0.47 +8.78%
Cosmos $6.57 +6.60%
Avalanche $36.24 +9.22%

Bitcoin $98,778.44 +3.09%
Ethereum $3,361.60 +8.93%
BNB $635.19 +5.34%
Optimism $2.04 +23.91%
Arbitrum $0.77 +14.74%
Solana $262.26 +11.19%
Polygon $0.47 +8.78%
Cosmos $6.57 +6.60%
Avalanche $36.24 +9.22%

SAB Biotherapeutics

company

Funding Round

Series B

Money Raised

$ 14M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Merck	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Sep 7, 2016	Grant	$ 1.42M	National Institutes of Health	Detail